Literature DB >> 7832267

Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.

D M Hartel1, E E Schoenbaum, P A Selwyn, J Kline, K Davenny, R S Klein, G H Friedland.   

Abstract

OBJECTIVES: The purpose of this study was to examine factors associated with heroin use during methadone maintenance treatment.
METHODS: Logistic regression statistical models were used to examine data obtained in a cross-sectional sample of 652 methadone patients.
RESULTS: Heroin use during the 3 months prior to interview was shown to be greatest among (1) patients maintained on methadone dosages of less than 70 mg/day (adjusted odds ratio [OR] = 2.1, 95% confidence interval [CI] = 1.3, 3.4) and (2) patients who used cocaine during treatment (adjusted OR = 5.9, 95% CI = 3.8, 9.1). These results were independent of treatment duration, treatment compliance, alcohol use, and socioeconomic factors. Cocaine users were more likely than nonusers of cocaine to use heroin at all methadone dosage levels.
CONCLUSIONS: This study confirms and extends past research showing high-dose methadone maintenance to be important to heroin abstinence. Further investigation of the independent association between heroin use and cocaine use is needed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7832267      PMCID: PMC1615273          DOI: 10.2105/ajph.85.1.83

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  23 in total

1.  Cocaine use and HIV infection in intravenous drug users in San Francisco.

Authors:  R E Chaisson; P Bacchetti; D Osmond; B Brodie; M A Sande; A R Moss
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

2.  Methadone treatment and the acquired immunodeficiency syndrome epidemic.

Authors:  V P Dole
Journal:  JAMA       Date:  1989 Sep 22-29       Impact factor: 56.272

3.  Role of drug-abuse treatment in limiting the spread of AIDS.

Authors:  R L Hubbard; M E Marsden; E Cavanaugh; J V Rachal; H M Ginzburg
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

4.  Reducing the risk of AIDS through methadone maintenance treatment.

Authors:  J C Ball; W R Lange; C P Myers; S R Friedman
Journal:  J Health Soc Behav       Date:  1988-09

5.  Inadequate plasma concentrations in some high-dose methadone maintenance patients.

Authors:  F S Tennant
Journal:  Am J Psychiatry       Date:  1987-10       Impact factor: 18.112

6.  Narcotic blockade.

Authors:  V P Dole; M E Nyswander; M J Kreek
Journal:  Arch Intern Med       Date:  1966-10

Review 7.  Cocaine and other stimulants. Actions, abuse, and treatment.

Authors:  F H Gawin; E H Ellinwood
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

Review 8.  Implications of methadone maintenance for theories of narcotic addiction.

Authors:  V P Dole
Journal:  JAMA       Date:  1988-11-25       Impact factor: 56.272

9.  ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans.

Authors:  M J Kreek; J Ragunath; S Plevy; D Hamer; B Schneider; N Hartman
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

10.  Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

Authors:  F H Gawin; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-02
View more
  37 in total

1.  Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Sara J Ward; Christopher Läck; Drake Morgan; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2006-01-14       Impact factor: 4.530

2.  Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.

Authors:  H M Rhoades; D Creson; R Elk; J Schmitz; J Grabowski
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Prediction of stress and drug craving ninety minutes in the future with passively collected GPS data.

Authors:  David H Epstein; Matthew Tyburski; William J Kowalczyk; Albert J Burgess-Hull; Karran A Phillips; Brenda L Curtis; Kenzie L Preston
Journal:  NPJ Digit Med       Date:  2020-03-04

4.  The impact of cocaine and heroin drug history on motivation and cue sensitivity in a rat model of polydrug abuse.

Authors:  Elizabeth A Crummy; Elizabeth A Donckels; Britahny M Baskin; Brandon S Bentzley; Susan M Ferguson
Journal:  Psychopharmacology (Berl)       Date:  2019-08-28       Impact factor: 4.530

5.  The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Authors:  August F Holtyn; Mikhail N Koffarnus; Anthony DeFulio; Sigurdur O Sigurdsson; Eric C Strain; Robert P Schwartz; Jeannie-Marie S Leoutsakos; Kenneth Silverman
Journal:  Prev Med       Date:  2014-03-04       Impact factor: 4.018

6.  Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.

Authors:  D M Hartel; E E Schoenbaum
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

7.  Structural-level factors affecting implementation of the methadone maintenance therapy program in China.

Authors:  Chunqing Lin; Zunyou Wu; Keming Rou; Wenyuan Yin; Changhe Wang; Steven Shoptaw; Roger Detels
Journal:  J Subst Abuse Treat       Date:  2009-12-16

8.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382

9.  Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco.

Authors:  Andrea M Lopez; Philippe Bourgois; Lynn D Wenger; Jennifer Lorvick; Alexis N Martinez; Alex H Kral
Journal:  Int J Drug Policy       Date:  2013-01-09

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.